|
Volume
23 Number 1
January 2021
|
|
Home
>
Publications
>
Current
Neuro-Oncology
> Volume
23, Year 2021
>
Number
1, January
|
|
|
Contents
|
▼
|
|
Central
nervous system tumors
|
|
Gliomas
|
|
○ High-grade
gliomas
|
|
○ Low-grade
gliomas
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
|
○
Diffuse
Astrocytoma
|
|
○
Anaplastic
Astrocytoma
|
|
○
Glioblastoma
|
|
○
Diffuse
Midline Glioma
|
|
Metastatic
tumors
|
|
|
Central
nervous system tumors
|
▲
|
|
Ayasoufi
K, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, Fain CE,
Yokanovich LT, Himes BT, Jin F, Zheng J, Schuelke MR, Hansen MJ,
Tung W, Parney IF, Pease LR, Vile RG, Johnson AJ.
Brain
cancer induces systemic immunosuppression through release of
non-steroid soluble mediators.
Brain.
2020 Nov 30. doi: 10.1093/brain/awaa343⍈
PMID:
33253355⍈
Laboratory
investigation. ⍈
|
|
|
|
Ma
Y, Lim DH, Cho H, Lee JW, Sung KW, Yoo KH, Koo HH, Shin HJ, Suh
YL.
Tandem
High-dose Chemotherapy without Craniospinal Irradiation in
Treatment of Non-metastatic Malignant Brain Tumors in Very Young
Children.
J
Korean Med Sci.
2020 Dec 14;35(48):e405. doi: 10.3346/jkms.2020.35.e405⍈
PMID:
33316857⍈
Clinical
study. ⍈
|
|
|
|
Marjańska
A, Drogosiewicz M, Dembowska-Bagińska B, Pawińska-WĄsikowska
K, Balwierz W, Bobeff K, MŁynarski W, Mizia-Malarz A,
Raciborska A, Wysocki M, Styczyński J.
Nivolumab
for the Treatment of Advanced Pediatric Malignancies.
Anticancer
Res.
2020 Dec;40(12):7095-7100. doi: 10.21873/anticanres.14738⍈
PMID:
33288608⍈
Case
series. ⍈
|
|
|
|
Nagtegaal
SHJ, David S, Philippens MEP, Snijders TJ, Leemans A, Verhoeff
JJC.
Dose-dependent
volume loss in subcortical deep grey matter structures after
cranial radiotherapy.
Clin
Transl Radiat Oncol.
2020 Nov 15;26:35-41. doi: 10.1016/j.ctro.2020.11.005⍈
PMID:
33294645⍈
Retrospective
analysis. ⍈
|
|
|
Gliomas
|
▲
|
|
Jiang
H, Deng G, Liu B, Cheng J, Li Y, Tan Y, Wang J, Chen Q.
Analysis
of the short-term outcomes and risk factors of seizure relapse in
patients with gliomas after antiepileptic drugs withdrawal.
J
Clin Neurosci.
2020 Nov 1. 2020;82(Pt A):20-25. doi: 10.1016/j.jocn.2020.09.051⍈
PMID:
33317732⍈
Retrospective
analysis.
⍈
|
|
|
|
Raysi
Dehcordi S, Galzio R, Marrone F, Di Vitantonio H, Marzi S, Fasano
T, Taddei G, Millimaggi D, Di Cosimo T, Abbate F, Calvisi G,
Masciocchi C, Ricci A.
Brain
location and tumor biological markers in high and low grade
gliomas: our experience.
J
Neurosurg Sci.
2020 Dec 15. doi: 10.23736/S0390-5616.20.05047-X⍈
PMID:
33320464⍈
Retrospective
analysis; ⍈
|
|
|
|
Seaman
SC, Bathla G, Park BJ, Woodroffe RW, Smith M, Menezes AH, Noeller
J, Yamaguchi S, Hitchon PW.
MRI
characteristics and resectability in spinal cord glioma.
Clin
Neurol Neurosurg.
2020 Oct 19. doi: 10.1016/j.clineuro.2020.106321⍈
PMID:
33268194⍈
Retrospective
analysis.
⍈
|
|
|
High-grade
gliomas
|
|
|
Silva
da Costa MD, Camargo NC, Dastoli PA, Nicácio JM, Benevides
Silva FA, Sucharski Figueiredo ML, Chen MJ, Cappellano AM, Saba da
Silva N, Cavalheiro S.
High-grade
gliomas in children and adolescents: is there a role for
reoperation?
J
Neurosurg Pediatr.
2020 Dec 11. doi: 10.3171/2020.7.PEDS20389⍈
PMID:
33307529⍈
Retrospective
analysis; ⍈
|
|
|
Low-grade
gliomas
|
|
|
Cacchione
A, Lodi M, Carai A, Miele E, Tartaglia M, Megaro G, Del Baldo G,
Alessi I, Colafati GS, Carboni A, Boccuto L, Diomedi Camassei F,
Catanzaro G, Po A, Ferretti E, Pedace L, Pizzi S, Folgiero V,
Pezzullo M, Corsetti T, Secco DE, Cefalo MG, Locatelli F,
Mastronuzzi A.
Upfront
treatment with mTOR inhibitor everolimus in pediatric Low-Grade
gliomas: A Single Center Experience.
Int
J Cancer.
2020 Dec 15. doi: 10.1002/ijc.33438⍈
PMID:
33320972⍈
Case
series; ⍈
|
|
|
|
Han
Y, Yang Y, Shi ZS, Zhang AD, Yan LF, Hu YC, Feng LL, Ma J, Wang W,
Cui GB.
Distinguishing
brain inflammation from grade II glioma in population without
contrast enhancement: a radiomics analysis based on conventional
MRI.
Eur
J Radiol.
2020 Dec 2;134:109467. doi: 10.1016/j.ejrad.2020.109467⍈
PMID:
33307462⍈
Retrospective
analysis. ⍈
|
|
|
|
Mato
D, Velasquez C, Gómez E, Marco de Lucas E, Martino J.
Predicting
the Extent of Resection in Low-Grade Glioma by Using Intratumoral
Tractography to Detect Eloquent Fascicles Within the
Tumor.
Neurosurgery.
2020 Dec 11. doi: 10.1093/neuros/nyaa463⍈
PMID:
33313812⍈
Retrospective
analysis. ⍈
|
|
|
|
Watson
J, Romagna A, Ballhausen H, Niyazi M, Lietke S, Siller S, Belka C,
Thon N, Nachbichler SB.
Long-term
outcome of stereotactic brachytherapy with temporary Iodine-125
seeds in patients with WHO grade II gliomas.
Radiat
Oncol.
2020 Dec 9;15(1):275. doi: 10.1186/s13014-020-01719-9⍈
PMID:
33298103⍈
Retrospective
analysis. ⍈
|
|
|
Diffuse
astrocytic and oligodendroglial tumors
|
▲
|
|
|
Diffuse
astrocytoma
|
|
|
Alshoabi
SA, Alareqi AA, Omer AM, Suliman AG, Daqqaq TS.
Diffuse
astrocytoma
and the diagnostic dilemma of an unusual phenotype: A case
report.
Radiol
Case Rep.
2020 Dec 3;16(2):319-326. doi: 10.1016/j.radcr.2020.11.023⍈
PMID:
33304444⍈
Case
report. ⍈
|
|
|
Anaplastic
astrocytoma
|
|
|
Khaddour
K, Harrison N, Govindan A, Campian JL.
Development
of Aplastic Anemia
during Treatment of Anaplastic Astrocytoma with Temozolomide.
Case
Rep Oncol.
2020 Oct 13;13(3):1244-1251. doi: 10.1159/000509744⍈
PMID:
33250738⍈
Case
report. ⍈
|
|
|
Glioblastoma
|
|
|
Curtin
L, Whitmire P, Rickertsen CR, Mazza GL, Canoll P, Johnston SK,
Mrugala MM, Swanson KR, Hu LS.
Assessment
of Prognostic Value of Cystic Features in Glioblastoma Relative to
Sex and Treatment With Standard-of-Care.
Front
Oncol.
2020 Nov 16;10:580750. doi: 10.3389/fonc.2020.580750⍈
PMID:
33282737⍈
Retrospective
analysis.
⍈
|
|
|
|
Elinzano
H, Toms S, Robison J, Mohler A, Carcieri A, Cielo D, Donnelly J,
Disano D, Vatketich J, Baekey J, Sturtevant A, MacKinnon K, Wood
R, Safran H.
Nanoliposomal
Irinotecan and Metronomic Temozolomide for Patients With Recurrent
Glioblastoma: BrUOG329, A Phase I Brown University Oncology
Research Group Trial.
Am
J Clin Oncol.
2020 Dec 4. doi: 10.1097/COC.0000000000000780⍈
PMID:
33284237⍈
Phase
1 trial; ⍈
|
|
|
|
Huang
J, Mehta M.
Can
proton therapy reduce radiation-related lymphopenia in
glioblastoma?
Neuro
Oncol.
2020 Dec 2:noaa273. doi: 10.1093/neuonc/noaa273⍈
PMID:
33263752⍈
Comment.
⍈
|
|
→Mohan
R, et al.
Proton Therapy Reduces the Likelihood of High-Grade
Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II
Randomized Study of Protons vs. Photons.
Neuro
Oncol.
2020 Aug 5:noaa182. doi: 10.1093/neuonc/noaa182⍈
PMID:
32750703⍈
Phase
2 trial. ⍈
|
|
|
|
Klein
P, Tyrlikova I, Zuccoli G, Tyrlik A, Maroon JC.
Treatment
of glioblastoma multiforme with "classic" 4:1 ketogenic
diet total meal replacement.
Cancer
Metab.
2020 Nov 9;8(1):24. doi: 10.1186/s40170-020-00230-9⍈
PMID:
33292598⍈
Prospective
study. ⍈
|
|
|
|
Rades
D, Witteler J, Leppert J, Schild SE.
Re-Irradiation
for Recurrent Glioblastoma Multiforme.
Anticancer
Res.
2020 Dec 7. 2020;40(12):7077-7081. doi: 10.21873/anticanres.14735⍈
PMID:
33288605⍈
Retrospective
analysis.
⍈
|
|
|
|
Stadlbauer
A, Kinfe TM, Eyüpoglu I, Zimmermann M, Kitzwoegerer M, Podar
K, Buchfelder M, Heinz G, Oberndorfer S, Marhold F.
Tissue
hypoxia and alterations in microvascular architecture predict
glioblastoma recurrence in humans.
Clin
Cancer Res.
2020 Dec 8. doi: 10.1158/1078-0432.CCR-20-3580⍈
PMID:
33293375⍈
Retrospective
analysis.
⍈
|
|
|
|
Tejada
S, Becerra-Castro MV, Nuñez-Cordoba
J, Díez-Valle R.
Ki-67
Proliferative Activity in the Tumor Margins as a Robust Prognosis
Factor in Glioblastoma Patients.
J
Neurol Surg A Cent Eur Neurosurg.
2020 Dec 1. doi: 10.1055/s-0040-1709730⍈
PMID:
33260244⍈
Prospective
study. ⍈
|
|
|
|
Topkan
E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi
Y, Pehlivan B, Selek U.
Systemic
Inflammation Response Index Predicts Survival Outcomes in
Glioblastoma Multiforme Patients Treated with Standard Stupp
Protocol.
J
Immunol Res.
2020 Nov 14;2020:8628540. doi: 10.1155/2020/8628540⍈
PMID:
33274245⍈
Retrospective
analysis. ⍈
|
|
|
*
|
Wu
B, Wang W, Wang H, Zou Q, Hu B, Ye L, Hu Y, Xie Y, Huang N, Lan Q,
Cheng H, Dong J, Dai X.
Single-Cell
Sequencing of Glioblastoma Reveals Central Nervous System
Susceptibility to SARS-CoV-2.
Front
Oncol.
2020 Nov 16;10:566599. doi: 10.3389/fonc.2020.566599⍈
PMID:
33312949⍈
Laboratory
investigation. ⍈
|
|
|
|
Zhang
M, Li R, Pollom EL, Amini A, Dandapani S, Li G.
Treatment
patterns and outcomes for cerebellar glioblastoma in the
concomitant chemoradiation era: A National Cancer database
study.
J
Clin Neurosci.
2020 Nov 6. 2020;82(Pt A):122-127. doi:
10.1016/j.jocn.2020.10.049⍈
PMID:
33317719⍈
Retrospective
analysis. ⍈
|
|
|
Diffuse
midline glioma
|
|
|
Dono
A, Takayasu T, Ballester LY, Esquenazi Y.
Adult
diffuse midline gliomas: Clinical, radiological, and genetic
characteristics.
J
Clin Neurosci.
2020 Nov 1. 2020;82(Pt A):1-8. doi: 10.1016/j.jocn.2020.10.005⍈
PMID:
33317715⍈
Retrospective
analysis. ⍈
|
|
|
|
Rasool
MT, Dar IA, Banday SZ, Banday AZ, Chibber SS, Choh NA, Baba MH,
Lone MM.
Modality
of Radiotherapy and Overall Survival in Pediatric Diffuse
Brainstem Gliomas: Implications for Resource-Constrained
Settings.
J
Trop Pediatr.
2020 Dec 5:fmaa105. doi: 10.1093/tropej/fmaa105⍈
PMID:
33280037⍈
Retrospective
analysis.
⍈
|
|
|
Metastatic
tumors
|
▲
|
|
Hanyu
T, Fujitani S, Ito A, Mizutani N.
Brain
metastasis from extramammary Paget's disease.
Nagoya
J Med Sci.
2020 Nov;82(4):791-798. doi: 10.18999/nagjms.82.4.791⍈
PMID:
33311809⍈
Case
report.
⍈
|
|
|
bottom
|
▲
|
***********************
|
|
